These results indicate a significant role for Jagged1 in hUC-MSC-induced survival and the self-maintenance of the Jurkat T-ALL cell line, making it a potential target for the treatment of human T-ALL. The gene discussed is JAG1; the disease is acute lymphoblastic leukemia.